Crexont Capsule, Extended Release
Product Images NDC 64896-968

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Crexont (NDC 64896-968). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cd Structural Formula (Crexont Carbidopa And Levodopa Extended Release Ca 1)

FDA Label Image

Ld Structural Formula (Crexont Carbidopa And Levodopa Extended Release Ca 2)

FDA Label Image

35-140 Ifc (Crexont Carbidopa And Levodopa Extended Release Ca 3)

This is a description of extended-release capsules containing carbidopa and levodopa in the amounts of 35 mg and 140 mg, respectively. The recommended dosage is specified in the prescribing information. The capsules should be stored at controlled room temperature and protected from light and moisture in a tightly closed container. It is important to keep the medication out of reach of children. These capsules are distributed by Amneal Specialty, a division of Amneal Pharmaceuticals LLC, located in Bridgewater, NJ.*

FDA Label Image

52-5-210 Ifc (Crexont Carbidopa And Levodopa Extended Release Ca 4)

This is a prescription drug information for CREXONT extended-release capsules containing 52.5 mg of carbidopa and 210 mg of levodopa. The recommended dosage should be in accordance with the prescribing information. It should be stored at temperatures between 20°C to 25°C in a closed container, protected from light and moisture. It is distributed by Amneal Specialty, a division of Amneal Pharmaceuticals LLC based in Bridgewater, NJ.*

FDA Label Image

70-280 Ifc (Crexont Carbidopa And Levodopa Extended Release Ca 5)

This text provides information about an extended-release capsule containing 70 mg of carbidopa, USP and 280 mg of levodopa, USP. It includes details about the recommended dosage, storage instructions, and the manufacturer - Amneal Specialty. The capsule is used in the treatment of certain conditions, and the prescription is required for obtaining 120 capsules.*

FDA Label Image

87-5-350 Ifc (Crexont Carbidopa And Levodopa Extended Release Ca 6)

This text is a medication label for extended-release capsules containing carbidopa and levodopa. The capsules are prescribed for specific dosages and require storage at controlled room temperature, protected from light and moisture. The medication is distributed by Amneal Specialty, a division of Amneal Pharmaceuticals LLC. The label also includes the NDC numbers and dosage information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.